ストックスクリーナーアプリを入手
41.66
1.51%
0.62
前日終値:
$41.04
開ける：
$41.2
24時間の取引高:
196.89K
Relative Volume:
0.84
時価総額：
$505.31M
収益：
$52.15M
当期純損益:
$24.35M
株価収益率:
28.64
EPS:
1.4544
ネットキャッシュフロー:
$-17.93M
1週間 パフォーマンス:
+1.96%
1か月 パフォーマンス:
+26.32%
6か月 パフォーマンス:
+24.81%
1年 パフォーマンス:
+73.87%
1日の値動き範囲:
$41.05
$41.75
1週間の範囲:
$40.61
$41.85
52週間の値動き範囲:
$22.29
$42.81
Xoma Royalty Corp Stock (XOMA) Company Profile
Compare XOMA vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
41.66 | 505.31M | 52.15M | 24.35M | -17.93M | 1.4544 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-17 | 開始されました | The Benchmark Company | Buy |
| 2024-04-29 | 開始されました | Leerink Partners | Outperform |
| 2021-09-07 | ダウングレード | Wedbush | Outperform → Neutral |
| 2021-06-29 | 開始されました | Aegis Capital | Buy |
| 2021-01-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-01-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-10-17 | 再開されました | H.C. Wainwright | Buy |
| 2017-09-05 | アップグレード | Wedbush | Neutral → Outperform |
| 2017-06-12 | 開始されました | H.C. Wainwright | Buy |
| 2016-11-14 | ダウングレード | Wedbush | Outperform → Neutral |
| 2016-03-11 | 繰り返されました | Wedbush | Outperform |
| 2015-07-23 | ダウングレード | Jefferies | Buy → Hold |
| 2015-07-22 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2015-07-22 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2014-10-10 | 再開されました | ROTH Capital | Buy |
| 2014-04-29 | アップグレード | MLV & Co | Hold → Buy |
| 2014-03-11 | ダウングレード | MLV & Co | Buy → Hold |
| 2014-03-05 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2013-10-31 | 繰り返されました | MLV & Co | Buy |
| 2013-05-09 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2012-05-14 | 開始されました | Cowen & Co | Outperform |
| 2011-03-31 | 繰り返されました | MLV Capital | Buy |
| 2011-03-23 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2011-01-06 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2011-01-04 | 繰り返されました | Wedbush | Outperform |
すべてを表示
Xoma Royalty Corp (XOMA) 最新ニュース
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
XOMA (XOMA) holders offered $39 cash plus CVRs in Ligand buyout - Stock Titan
Ligand Pharmaceuticals Launches Takeover Plan at XOMA Royalty Corporation with 47.0% Stake - TradingView
This Appian Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Thursday - Sahm
[SCHEDULE 13G] XOMA Royalty Corp Passive Investment Disclosure (>5%) - Stock Titan
H.C. Wainwright cuts XOMA stock rating on Ligand acquisition - Investing.com
HC Wainwright & Co. downgrades XOMA Royalty (XOMA) - MSN
BVF group backs XOMA Royalty Corp (XOMA) merger with 21.4% locked-up stake - Stock Titan
LGND: XOMA Buy Adds 100+ Assets - Yahoo Finance
XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law Firm - GlobeNewswire
XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law Firm - GlobeNewswire Inc.
Ligand to acquire XOMA Royalty - The Pharma Letter
XOMA Royalty (XOMA) Moves 10.7% Higher: Will This Strength Last? - Yahoo Finance
Ligand Pharmaceuticals to Buy XOMA Royalty for $39/Share, Lifts 2026 Guidance and EPS Outlook - MarketBeat
BlackRock (NASDAQ: XOMA) reports 5.4% stake in XOMA Royalty Corp - Stock Titan
XOMA (XOMA) closes Generation Bio acquisition, details cash-plus-CVR terms and LNP assets - Stock Titan
Are OGN, RMAX, XOMA, REAX Obtaining Fair Deals for their Shareholders? - The Malaysian Reserve
HC Wainwright & Co. maintains XOMA Royalty (XOMA) buy recommendation - MSN
Promising Biotech Stocks To Watch TodayApril 27th - MarketBeat
Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million - Benzinga
Ligand Is Buying Xoma Royalty For $739 Million In Cash - Finimize
Ligand Pharmaceuticals Incorporated entered into a definitive agreement to acquire XOMA Royalty Corporation for approximately $470 million from BVF Partners L.P. and others. - marketscreener.com
Ademi LLP Investigates XOMA for Possible Violations - Intellectia AI
Xoma Royalty Corp - Reuters
XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday - Benzinga
Ademi LLP Investigates Whether XOMA Royalty Corporation Is Obtaining a Fair Price for Public Shareholders - Moomoo
Ligand (Nasdaq: LGND) to acquire XOMA Royalty in $739M, EPS‑accretive deal - Stock Titan
Ligand Pharmaceuticals buying Xoma Royalty for $739 million - Yahoo Finance
Ligand Pharmaceuticals to Acquire XOMA Royalty for $739 Million, Expanding Biopharma Royalty Portfolio and Boosting 2026 EPS Guidance - Minichart
XOMA Royalty to Be Acquired by Ligand in $39-Per-Share Cash Deal Plus CVRs - TradingView
XOMA Stock Alert: Halper Sadeh LLC is Investigating Whether XOMA Royalty Corporation is Obtaining a Fair Price for its Shareholders - Business Wire
Ligand to buy XOMA Royalty (Nasdaq: XOMA) in $739M cash and CVR deal - Stock Titan
XOMA Royalty: Transaction Is Expected to Close in the 3Q of 2026 >XOMA - Moomoo
Ligand to acquire XOMA Royalty for $739 million in cash - Investing.com
Ligand to acquire XOMA Royalty for $739 million in cash By Investing.com - Investing.com Australia
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator - The Manila Times
XOMA Stock Price, Quote & Chart | XOMA ROYALTY CORPORATION (NASDAQ:XOMA) - ChartMill
XOMA Royalty (NASDAQ:XOMA) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
XOMA (XOMA) CFO converts 11,538 Performance Stock Units into common shares - Stock Titan
XOMA (XOMA) legal chief converts 3,370 PSUs into common shares - Stock Titan
XOMA (XOMA) CEO Owen Hughes exercises 10,568 PSUs and updates holdings - Stock Titan
XOMA (XOMA) CIO boosts direct common holdings via 3,737 PSU conversion - Stock Titan
XOMA Technical Analysis & Stock Price Forecast - Intellectia AI
XOMA ROYALTY CORPXOMA 8 3/8 PERP (NASDAQ:XOMAO) Checks All Eight Boxes in Navellier’s Little Book Growth Screen - ChartMill
XOMA (XOMA) CFO exercises 4,000 PSUs, 1,632 shares withheld for taxes - Stock Titan
XOMA Royalty Corporation (NASDAQ:XOMA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
XOMA Corp8.375% DP PFD B declares $0.5234 dividend - MSN
Published on: 2026-04-13 23:42:40 - baoquankhu1.vn
XOMA Royalty (NASDAQ:XOMA) Upgraded at Zacks Research - Defense World
GBIO SEC FilingsGeneration Bio Co. 10-K, 10-Q, 8-K Forms - Stock Titan
Retail Surge: Is now the right time to enter XOMA Royalty Corporation2026 Fundamental Recap & Real-Time Buy Signal Alerts - baoquankhu1.vn
Xoma Royalty Corp (XOMA) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):